Disclosure of Conflicts of Interest
AXIS Medical Education requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
AXIS will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Name of Faculty or Presenter
Reported Financial Relationship
Ingrid A. Mayer, MD
Ingrid A. Mayer, MD, reported a financial interest/relationship or affiliation in the form of Advisor: Novartis Pharmaceuticals Corp; Genentech, Inc; Eli Lilly and Co; GlaxoSmithKline; MacroGenics, Inc; Seattle Genetics, Inc; Immunomedics, Inc; and AstraZeneca Pharmaceuticals LP. Research grant: Pfizer, Inc; and Genentech, Inc.
Robert Mocharnuk, MD
Robert Mocharnuk, MD, reported a financial interest/relationship or affiliation in the form of Common stock: Merck.
The following AXIS planners and managers, Jocelyn Timko and Marilyn Haas, PhD, RN, CNS, ANP-BC hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest of any amount during the past 12 months. Linda Gracie-King, MS (spouse) reports a financial interest/relationship or affiliation in the form of Common stock: Exelixis. Robert Mocharnuk, MD, reports a financial interest/relationship or affiliation in the form of Common stock: Merck.